We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
- Authors
Small, Eric J; Schellhammer, Paul F; Higano, Celestia S; Redfern, Charles H; Nemunaitis, John J; Valone, Frank H; Verjee, Suleman S; Jones, Lori A; Hershberg, Robert M
- Abstract
Sipuleucel-T (APC8015) is an investigational immunotherapy product designed to stimulate T-cell immunity against prostatic acid phosphatase. A phase III study was undertaken to evaluate the safety and efficacy of sipuleucel-T in a placebo-controlled study.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 19, p3089
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.04.5252